PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2011
Amended Announcements
Please refer to the earlier announcement reference number: PB-120220-40927
PHARMANIAGA BERHAD |
Financial Year End | 31/12/2011 |
Quarter | 4 |
Quarterly report for the financial period ended | 31/12/2011 |
The figures | have not been audited |
Remarks : |
1. Dividend for current quarter of 30 sen comprises:- i) Interim Dividend of 9 sen per share, less taxation of 25% declared for 4th quarter ended 31 December 2011 which was paid on 26 January 2012. ii) Single tier dividend of 21 sen per share declared for 4th quarter ended 31 December 2011 payable on 28 March 2012. 2. The Basic Earnings per Share ("EPS") were calculated based on weighted average number of shares inclusive of bonus issue as approved by the Board on 22 December 2011 and subsequently completed on 20 February 2012. The EPS for the preceding year corresponding quarter and year have been restated to reflect the retrospective adjustments arising from the aforementioned bonus issue. |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2011 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2011 | 31/12/2010 | 31/12/2011 | 31/12/2010 | ||
$$'000 | $$'000 | $$'000 | $$'000 | ||
1 | Revenue | 367,786 | 376,116 | 1,520,981 | 1,378,348 |
2 | Profit/(loss) before tax | 16,368 | -2,701 | 73,186 | 45,462 |
3 | Profit/(loss) for the period | 12,182 | -1,952 | 52,785 | 30,310 |
4 | Profit/(loss) attributable to ordinary equity holders of the parent | 11,942 | -2,256 | 52,157 | 30,384 |
5 | Basic earnings/(loss) per share (Subunit) | 10.15 | -1.92 | 44.32 | 25.82 |
6 | Proposed/Declared dividend per share (Subunit) | 30.00 | 0.00 | 30.00 | 10.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share attributable to ordinary equity holders of the parent ($$) | 4.3700 | 3.9400 |
Remarks : |
Amendment to item No. 6: The individual and cumulative quarter for the current year to date proposed/declared dividend per share (subunit) should state 30.00 instead of 21.00, taking into account the earlier dividend of 9.00 sen per share paid on 26 January 2012. Amendments to the Notes: B21. In line 2 in previous disclosure, "In this respect, BHB will undertake restricted offer for sale of ...." should read "In this respect, BHB will undertake divestment of shares of....." B28. In previous disclosure, the weighted average number of ordinary shares in issue ('000) was "117,676" should read "117,674". In line 2 in previous disclosure, "arising from Bonus Issue of 10,697,800 shares..." should read "arising from actual Bonus Issue of 10,696,181 shares as mentioned in Note B21 (ii)." |
Definition of Subunit:
In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 22 Feb 2012 |
Category | Financial Results |
Reference No | PB-120222-ECBF9 |